Multiple sclerosis treatment underutilization predicts high risk for obstructive sleep apnea in patients with multiple sclerosis.
John Patrick DempseyAlexandra BalshiAndrew BouleyEmily EgnorSoleil SamaanUrsela BaberJacob A Sloane
Published in: Multiple sclerosis and related disorders (2024)
We identified disease-modifying therapy (DMT) underutilization, fatigue, and nonwhite race as predictors of high OSA risk in patients with MS. These findings support aggressive treatment of MS to avoid risk of comorbid OSA and MS-induced fatigue.